References
- Bonsib SM, Bergstein J. ARF with casts eliciting a cellular reaction. Am J Kidney Dis. 2004;43(6):1138–1141
- Ivanyi B, Rumpelt HJ, Thoenes W. Acute human pyelonephritis: leukocytic infiltration of tubules and localization of bacteria. Virchows Archiv A Patholog Anatomy Histopathol. 1988;414(1):29–37
- Herrera GA PM. Renal Diseases Associated with Plasma Cell Dyscrasias, Amyloidosis, Waldenstrom Macroglobulinemia, and Cryoglobulinemic Nephropathies. Vol. 2, 6th ed. Philadelphia, PA: Lippincott, Williams, and Wilkins; 2007
- Larsen CP, Bell JM, Harris AA, Messias NC, Wang YH, Walker PD. The morphologic spectrum and clinical significance of light chain proximal tubulopathy with and without crystal formation. Modern Pathol. 2011;24(11):1462–1469
- Sethi S, Hanna MH, Fervenza FC. Unusual casts in a case of multiple myeloma. Am J Kidney Dis. 2009;54(5):970–974
- Gu X, Herrera GA. Light-chain-mediated acute tubular interstitial nephritis: a poorly recognized pattern of renal disease in patients with plasma cell dyscrasia. Arch Pathol Lab Med. 2006;130(2):165–169
- Seshan SV, D'Agati VD, Appel GA, Churg J, eds. Renal disease classification and Atlas of tubulo-interstitial and vascular diseases. In Tubulo-interstitial and Vascular Lesions Associated with Neoplastic Disorders. Baltimore, MD: Williams and Wilkins; 1999
- Huang ZQ, Kirk KA, Connelly KG, Sanders PW. Bence Jones proteins bind to a common peptide segment of Tamm-Horsfall glycoprotein to promote heterotypic aggregation. J Clin Invest. 1993;92(6):2975–2983
- Cohen AH, Border WA. Myeloma kidney. An immunomorphogenetic study of renal biopsies. Lab Invest A J Tech Methods Pathol. 1980;42(2):248–256
- Sedmak DD, Tubbs RR. The macrophagic origin of multinucleated giant cells in myeloma kidney: an immunohistologic study. Human Pathol. 1987;18(3):304–306
- Solomon A, Weiss DT, Kattine AA. Nephrotoxic potential of Bence Jones proteins. New Engl J Med. 1991;324(26):1845–1851
- Comenzo RL, Zhang Y, Martinez C, Osman K, Herrera GA. The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig V(L) germ line gene use and clonal plasma cell burden. Blood. 2001;98(3):714–720
- Aucouturier P, Bauwens M, Khamlichi AA, et al. Monoclonal Ig L chain and L chain V domain fragment crystallization in myeloma-associated Fanconi's syndrome. J Immunol. 1993;150(8 Pt 1):3561–3568
- Deret S, Chomilier J, Huang DB, Preud'homme JL, Stevens FJ, Aucouturier P. Molecular modeling of immunoglobulin light chains implicates hydrophobic residues in non-amyloid light chain deposition disease. Protein Eng. 1997;10(10):1191–1197
- Abraham RS, Geyer SM, Price-Troska TL, et al. Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL). Blood. 2003;101(10):3801–3808
- Cohen G, Horl WH. Free immunoglobulin light chains as a risk factor in renal and extrarenal complications. Semin Dial. 2009;22(4):369–372
- Kreft B, Jabs WJ, Laskay T, et al. Polarized expression of Tamm-Horsfall protein by renal tubular epithelial cells activates human granulocytes. Infect Immun. 2002;70(5):2650–2656